Rejuvas Biotech India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-12-2024
- Paid Up Capital ₹ 0.10 M
as on 30-12-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 61.31%
(FY 2022)
- Ebitda 81.37%
(FY 2022)
- Net Worth -9.59%
(FY 2022)
- Total Assets 3.63%
(FY 2022)
About Rejuvas Biotech India
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Agarwal and Sabita Agarwal serve as directors at the Company.
- CIN/LLPIN
U73200WB2019PTC232523
- Company No.
232523
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rejuvas Biotech India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Agarwal  | Director | 19-Jun-2019 | Current |
| Sabita Agarwal | Director | 19-Jun-2019 | Current |
Financial Performance of Rejuvas Biotech India.
Rejuvas Biotech India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 61.31% increase in profit. The company's net worth dipped by a decrease of 9.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rejuvas Biotech India?
Unlock access to Rejuvas Biotech India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mas Superalloys Private LimitedActive 24 years 8 monthsAjay Agarwal and Sabita Agarwal are mutual person
- Techevo Engineering Private LimitedActive 4 years 29 days
Ajay Agarwal and Sabita Agarwal are mutual person
- Mas Transformers Private LimitedActive 44 years 10 months
Ajay Agarwal and Sabita Agarwal are mutual person
- Basuki It Solutions Private LimitedActive 10 years 9 months
Ajay Agarwal and Sabita Agarwal are mutual person
- Flaig Hommel (India) Private LimitedActive 5 years 9 months
Ajay Agarwal and Sabita Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rejuvas Biotech India?
Unlock and access historical data on people associated with Rejuvas Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rejuvas Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rejuvas Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
